We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Opinionated Science Episode 6: COVID-19: Repurposing Drugs, Hydroxychloroquine and Clinical Trials

Opinionated Science is Technology Networks’ homemade podcast, where our team of scientists-turned-journalists cut out the chewy jargon and serve up slices of the most fascinating stories from the world of science. Expect a new Opinionated Science every other Friday.

In this episode, the Technology Networks team discusses drug treatments to combat SARS-CoV-2. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic? 

Read more from this podcast: 

Hydroxychloroquine Revived by WHO

How modeling can support drug development

Covid-19 brings drug development to a halt

Tackling Covid-19: ongoing drug development efforts

Flooded by the torrent: the COVID-19 drug pipeline

Global impact on clinical trials

What is a preprint? 

Exploring the drug development process

Keep up to date with COVID-19 vaccine development


Hydroxychloroquine arm stopped in RECOVERY Trial

Listen to more Technology Networks podcasts here.

Meet the Authors
Laura Elizabeth Lansdowne
Laura Elizabeth Lansdowne
Managing Editor
Ruairi J Mackenzie
Ruairi J Mackenzie
Senior Science Writer
Tiffany Quinn
Tiffany Quinn
Custom Content Manager